Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL11555178 | 0.85 | LMNA (0.39) | LMNAALDH1A1 | |
| Propanol SCHEMBL3361399 | 0.85 | LMNA (0.39) | LMNAALDH1A1 | |
| Ethylene Glycol SCHEMBL14977446 | 0.83 | LMNA (0.38) | LMNAALDH1A1 | |
| Alcohol SCHEMBL28150417 | 0.83 | LMNA (0.40) | TSHRLMNAALDH1A1 | |
| Methyl Alcohol SCHEMBL9617023 | 0.80 | LMNA (0.41) | LMNA | |
| SCHEMBL8130395 | 0.80 | LMNA (0.44) | LMNA | |
| SCHEMBL35169 | 0.80 | LMNA (0.44) | LMNA | |
| Hydrochloric Acid SCHEMBL21043558 | 0.79 | LMNA (0.31) | TSHRLMNA | |
| Methylamine SCHEMBL3982375 | 0.78 | TSHR (0.32) | TSHRALDH1A1 | |
| SCHEMBL28880717 | 0.78 | LMNA (0.40) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210349109-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2021-11-11 | — | — | US | claimed |
| US-10955424-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2021-03-23 | — | — | US | claimed |
| US-20170261523-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2017-09-14 | — | — | US | claimed |
| US-9506937-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2016-11-29 | — | — | US | claimed |
| US-20160061848-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2016-03-03 | — | — | US | claimed |
| US-9034653-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INC. (US) | 2015-05-19 | — | — | US | claimed |
| US-20130137185-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2013-05-30 | — | — | US | claimed |
| US-20230375575-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2023-11-23 | — | — | US | disclosed |
| US-11808773-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2023-11-07 | — | — | US | disclosed |
| US-20210349109-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2021-11-11 | — | — | US | disclosed |
| US-10955424-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2021-03-23 | — | — | US | disclosed |
| EP-3693734-A2 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | Quest Diagnostics Investments Incorporated (US) | 2020-08-12 | — | — | EP | disclosed |
| EP-2510347-B1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEX SAMPLES | QUEST DIAGNOSTICS INVEST INC (US) | 2019-03-20 | — | — | EP | disclosed |
| US-9506937-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160061848-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2016-03-03 | — | — | US | disclosed |
| US-9034653-B2 | Mass spectrometry of steroidal compounds in multiplexed patient samples | QUEST DIAGNOSTICS INVESTMENTS INC. (US) | 2015-05-19 | — | — | US | disclosed |
| US-20140371386-A1 | PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2014-12-18 | — | — | US | disclosed |
| EP-2782965-A1 | PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS | Momentive Performance Materials Inc. (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2013078450-A1 | PROCESS FOR MAKING ORGANIC-INORGANIC HYBRID MATERIALS | MOMENTIVE PERFORMANCE MATERIALS, INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| US-20130137185-A1 | MASS SPECTROMETRY OF STEROIDAL COMPOUNDS IN MULTIPLEXED PATIENT SAMPLES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2013-05-30 | — | — | US | disclosed |